Association between anti-thymocyte globulin exposure and clinical outcomes of adult undergoing haploidentical hematopoietic stem cell transplantation with myeloablative conditioning: a pharmacokinetic-guided study.
BACKGROUND Rabbit antithymocyte globulin (rATG) plays a critical role in preventing graft-versus-host disease (GVHD) after haploidentical hematopoietic stem cell transplantation (haplo-HSCT). However, conventional weight-based dosing results in substantial interpatient variability in active rATG exposure, potentially a...